This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Integra LifeSciences Announces Two Key Executive Appointments

Stocks in this article: IART

PLAINSBORO, N.J., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that John Mooradian and Joseph Vinhais have joined Integra as Senior Vice President, Global Operations and Supply Chain, and Senior Vice President, Global Quality Assurance, respectively, reporting to Peter Arduini, President and CEO.

"I am delighted to have John and Joseph at Integra," said Mr. Arduini. "John brings a depth of operations experience that will be invaluable as we continue evolving our global manufacturing strategy and maximizing our supply chain effectiveness. Joseph will apply his extensive quality and regulatory experience to drive continuous improvement throughout the organization."

Mr. Mooradian, as Senior Vice President of Global Operations and Supply Chain, will be responsible for Integra's newly integrated global manufacturing and supply chain functions. Prior to joining Integra, Mr. Mooradian spent 24 years at Abbott Laboratories in a series of leadership roles, where he significantly improved critical manufacturing processes and systems, and implemented key compliance enhancements. One of Mr. Mooradian's key roles at Abbot was responsibility for worldwide operations at Abbott Diagnostics Division, a $4 billion business with over 11,000 employees.

Mr. Vinhais, as Senior Vice President of Global Quality Assurance, will be responsible for Integra's global quality systems.  Mr. Vinhais has over 20 years of global experience in quality assurance, regulatory affairs, compliance, and operations. He was most recently Head of Quality Assurance, Regulatory Affairs, and Sustainability at Philips Healthcare Imaging Systems, where he was responsible for quality assurance and regulatory affairs for the Computed Tomography and Nuclear Medicine business. During his tenure at Philips, Mr. Vinhais played an integral role in developing quality and regulatory strategies for China, as well as other emerging markets, and realigning the quality and regulatory functions to better support the business. Judi O'Grady, Senior Vice President, Global Regulatory Affairs, will lead the Regulatory Affairs department on a global basis.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs